Document ID: chunk:federal_register_of_legislation:F2024L00224:reg:4
Version: federal_register_of_legislation:F2024L00224
Segment Type: reg
Provision Reference: reg 4
Character Range: 945–1888

4               Amendment
The Statements of Principles concerning;
 malignant neoplasm of the lung (Reasonable Hypothesis) (No. 86 of 2023) (Federal Register of Legislation No. F2023L01145)
soft tissue sarcoma (Reasonable Hypothesis) (No. 76 of 2023) (Federal Register of Legislation No. F2023L01136)
Hodgkin lymphoma (Reasonable Hypothesis) (No. 70 of 2023) (Federal Register of Legislation No. F2023L00948)
malignant neoplasm of the prostate (Reasonable Hypothesis) (No. 3 of 2023) (Federal Register of Legislation No. F2023L00001)
malignant neoplasm of the larynx (Reasonable Hypothesis) (No. 41 of 2022) (Federal Register of Legislation No. F2022L00660)
myeloma (Reasonable Hypothesis) (No. 95 of 2021) (Federal Register of Legislation No. F2021L01182)
non-Hodgkin lymphoma (Reasonable Hypothesis) (No. 90 of 2018) (Federal Register of Legislation No. F2018L01489)

Are amended in the following manner:

Section                  Amendment